![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
5 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Four-Year Results: The EVOLUT Low Risk Trial Talking Points
-
- Ciencia
Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR.
Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR.
5 min